PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Successful management of a complicated clinical crisis: A patient with left-sided endocarditis and secondary hemophagocytic lymphohistiocytosis: a rare case report and literature review.

Abstract Hemophagocytic lymphohistiocytosis (HLH) secondary to methicillin-resistant Staphylococcus epidermidis (MRSE)-related left-sided infectious endocarditis had never been reported before. In the last decade, daptomycin, a novel lipopeptide antibiotic, showed its excellent role in anti-Gram-positive bacteria, including soft tissue infection, bloodstream and deep tissueinfection.
PMID
Related Publications

In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.

High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review.

Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.

Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.

Authors

Mayor MeshTerms

Methicillin-Resistant Staphylococcus aureus

Keywords
Journal Title medicine
Publication Year Start




PMID- 29390580
OWN - NLM
STAT- MEDLINE
DCOM- 20180212
LR  - 20180212
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 51
DP  - 2017 Dec
TI  - Successful management of a complicated clinical crisis: A patient with left-sided
      endocarditis and secondary hemophagocytic lymphohistiocytosis: a rare case report
      and literature review.
PG  - e9451
LID - 10.1097/MD.0000000000009451 [doi]
AB  - RATIONALE: Hemophagocytic lymphohistiocytosis (HLH) secondary to
      methicillin-resistant Staphylococcus epidermidis (MRSE)-related left-sided
      infectious endocarditis had never been reported before. In the last decade,
      daptomycin, a novel lipopeptide antibiotic, showed its excellent role in
      anti-Gram-positive bacteria, including soft tissue infection, bloodstream and
      deep tissueinfection. PATIENT CONCERNS: An Asian women under sever condition due 
      to the cooccurrence of HLH and MRSE-related endocarditis while also be allergic
      to vancomycin. The patient was cured by high-dose daptomycin monotheraphy,
      HLH-2004 protocol and cardiothoracic surgery to remove the valve at last, and was
      obviously benefit from the endeavor of a multidisciplinary team (MDT) strategy.
      DIAGNOSES: IE was made on March 27according to the modified Duke criteria. HLH
      was diagnosed too. INTERVENTIONS: The patient was cured by high-dose daptomycin
      monotheraphy, HLH-2004 protocol and cardiothoracic surgery to remove the valve at
      last, and was obviously benefit from the endeavor of a multidisciplinary team
      (MDT) strategy. OUTCOMES: The patient was healthy andstable when we published
      this case. LESSONS: This case proves high-dose daptomycin monotheraphy could be
      used as an effective alternative regimen for vancomycin in treating MRSE-related 
      left-sided endocarditis and highlight the importance of early diagnosis and
      appropriate management for HLH. Furthermore, our work suggests an MDT model as a 
      practical strategy in managing similar clinical situation.
CI  - Copyright (c) 2017 The Authors. Published by Wolters Kluwer Health, Inc. All
      rights reserved.
FAU - Xu, Peipei
AU  - Xu P
FAU - Zeng, Hui
AU  - Zeng H
FAU - Zhou, Min
AU  - Zhou M
FAU - Ouyang, Jian
AU  - Ouyang J
FAU - Chen, Bing
AU  - Chen B
FAU - Zhang, Qiguo
AU  - Zhang Q
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Anti-Bacterial Agents)
RN  - NWQ5N31VKK (Daptomycin)
SB  - AIM
SB  - IM
MH  - Adult
MH  - Anti-Bacterial Agents/therapeutic use
MH  - Combined Modality Therapy
MH  - Daptomycin/therapeutic use
MH  - Endocarditis, Bacterial/*complications/microbiology/surgery/therapy
MH  - Female
MH  - Humans
MH  - Lymphohistiocytosis, Hemophagocytic/*complications/etiology/microbiology
MH  - *Methicillin-Resistant Staphylococcus aureus
MH  - Staphylococcal Infections/*complications/microbiology
PMC - PMC5758282
EDAT- 2018/02/03 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/03 06:00
PHST- 2018/02/03 06:00 [entrez]
PHST- 2018/02/03 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
AID - 10.1097/MD.0000000000009451 [doi]
AID - 00005792-201712220-00167 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Dec;96(51):e9451. doi: 10.1097/MD.0000000000009451.